Abstract | BACKGROUND: PURPOSE: METHODS: The neuroprotective effects of YQFM were investigated in vivo in mice with middle cerebral artery occlusion/reperfusion (MCAO/R) (n = 6) by detecting neurological deficits, infarct volume, and histopathological changes. The NMMHC IIA-actin-ATG9A interaction was determined using immunofluorescence co-localization, co-immunoprecipitation, and proximity ligation assay. Rat pheochromocytoma (PC12) cells subjected to oxygen- glucose deprivation/reoxygenation (OGD/R) were used to mimic neurons in in vitro experiments. RESULTS: In MCAO/R model mice, YQFM (1.342 g/kg) attenuated brain ischemia/reperfusion-induced injury by regulating NMMHC IIA-actin-mediated ATG9A trafficking. YQFM (400 μg/ml) also exerted similar effects on OGD/R-induced PC12 cells. Furthermore, RNAi of NMMHC IIA weakened the NMMHC IIA- F-actin-dependent ATG9A trafficking and, therefore, attenuated the neuroprotective activities of YQFM in vitro. CONCLUSION: These findings demonstrated that YQFM exerted neuroprotective effects by regulating the NMMHC IIA-actin-ATG9A interaction for autophagosome formation. This evidence sheds new light on the potential mechanism of YQFM in the treatment of cerebral ischemia/reperfusion.
|
Authors | Linjie Su, Yining Liu, Huifen Ma, Fan Zheng, Yujie Daia, Tiezheng Wang, Guangyun Wang, Fang Li, Yuanyuan Zhang, Boyang Yu, Shuaishuai Gong, Junping Kou |
Journal | Phytomedicine : international journal of phytotherapy and phytopharmacology
(Phytomedicine)
Vol. 95
Pg. 153882
(Jan 2022)
ISSN: 1618-095X [Electronic] Germany |
PMID | 34968897
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021. Published by Elsevier GmbH. |
Chemical References |
- ATG9A protein, rat
- Actins
- Atg9A protein, mouse
- Autophagy-Related Proteins
- Drugs, Chinese Herbal
- Membrane Proteins
- Neuroprotective Agents
- Vesicular Transport Proteins
- yi-qi-fu-mai
|
Topics |
- Actins
- Animals
- Autophagy
- Autophagy-Related Proteins
- Brain Ischemia
(drug therapy)
- Drugs, Chinese Herbal
(pharmacology)
- Membrane Proteins
- Mice
- Neuroprotective Agents
(pharmacology)
- Rats
- Reperfusion Injury
(drug therapy)
- Vesicular Transport Proteins
|